XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
REVENUES:        
Revenue $ 134,397 $ 125,343 $ 394,611 $ 381,580
OPERATING EXPENSES:        
General and administrative expense, exclusive of depreciation expense shown below 8,642 9,452 30,690 31,594
Depreciation 3,551 3,802 10,909 11,548
Amortization 125 127 380 362
Other (income) expense, net (4,529) 673 (6,073) (423)
OPERATING INCOME 19,803 14,672 44,382 40,059
Interest expense 3,108 3,147 9,740 9,812
Income before income taxes 16,695 11,525 34,642 30,247
Income tax expense (benefit) 4,691 2,305 9,958 (4,344)
Net income 12,004 9,220 24,684 34,591
Net income (loss) attributable to non-controlling interest 259 (37) 687 115
Net income attributable to Core Laboratories Inc. $ 11,745 $ 9,257 $ 23,997 $ 34,476
EARNINGS PER SHARE INFORMATION:        
Basic earnings per share $ 0.26 $ 0.2 $ 0.53 $ 0.74
Basic earnings per share attributable to Core Laboratories Inc. 0.25 0.2 0.51 0.74
Diluted earnings per share 0.25 0.19 0.52 0.73
Diluted earnings per share attributable to Core Laboratories Inc. $ 0.25 $ 0.19 $ 0.5 $ 0.73
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic 46,922 46,692 46,897 46,667
Diluted 47,820 47,604 47,690 47,536
Service [Member]        
REVENUES:        
Revenue $ 98,842 $ 92,883 $ 291,674 $ 277,224
OPERATING EXPENSES:        
Cost of services and product sales exclusive of depreciation expense shown below 75,503 68,976 224,191 211,031
Product [Member]        
REVENUES:        
Revenue 35,555 32,460 102,937 104,356
OPERATING EXPENSES:        
Cost of services and product sales exclusive of depreciation expense shown below $ 31,302 $ 27,641 $ 90,132 $ 87,409